drugset / Trial / NCT04156906

RHD Genotype Matched Red Cells for Anti-D

NCT04156906 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study to evaluate the feasibility and safety of providing RH genotype matched D+ Red Blood Cells (RBCs) to chronically transfused patients with sickle cell disease (SCD) who type D+ but have formed anti-D and are currently transfused with D- RBC (Red Blood Cell) units.

Timeline

Start
2020-07-08
Primary completion
2024-03-04
Completion
2024-10-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject D+ RH genotype matched red cell units for transfusion Unknown — Other